| abstract |
The present invention relates to the compound () -6- [amino- (6-chloro-pyridin-3-yl) - (3-methyl-3H-imidazol-4-yl) -methyl] -4- (3-chloro -phenyl) -1-cyclopropylmethyl-1H-quinolein-2-one, pharmaceutically acceptable salts and solvates thereof, and prodrugs thereof, and the use of said compound to inhibit abnormal cell development, including cancer, in mammalian animals. The invention also relates to methods useful for synthesizing the said compound. |